MoneyWorks4Me

Concord Drugs - Quaterly Results

11 Aug 2026 Evaluate
A decent increase of about 56.13% in the turnover to Rs. 208.97 millions was observed for the quarter ended June 2026. The turnover stood at Rs. 133.84 millions during the similar quarter previous year.Net Profit for the quarter ended June 2026 zoomed to 892.86% from Rs. 1.12 millions to Rs. 11.12  millions.OP of the company witnessed a marginal growth to 22.41 millions from 9.39 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 208.97 133.84 56.13 208.97 133.84 56.13 758.83 369.46 105.39
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 22.41 9.39 138.66 22.41 9.39 138.66 42.64 37.77 12.89
Interest 3.51 4.20 -16.43 3.51 4.20 -16.43 14.59 17.18 -15.08
PBDT 18.90 5.19 264.16 18.90 5.19 264.16 28.05 20.59 36.23
Depreciation 3.48 3.66 -4.92 3.48 3.66 -4.92 13.57 14.18 -4.30
PBT 15.42 1.53 907.84 15.42 1.53 907.84 14.48 6.41 125.90
TAX 4.30 0.41 948.78 4.30 0.41 948.78 4.11 3.46 18.79
Deferred Tax -0.11 -0.11 0.00 -0.11 -0.11 0.00 -0.02 1.56 -101.28
PAT 11.12 1.12 892.86 11.12 1.12 892.86 10.37 2.95 251.53
Equity 131.75 100.00 31.75 131.75 100.00 31.75 131.75 100.00 31.75
PBIDTM(%) 10.72 7.02 52.85 10.72 7.02 52.85 5.62 10.22 -45.03

Concord Drugs Share Price

70.40 -2.49 (-3.42%)
17-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1882.50
Dr. Reddys Labs. 1192.00
Cipla 1430.00
Lupin 2259.20
Zydus Lifesciences 1132.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: